Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Clinical trial NCT02195869 · COMPLETED
Trial details
- NCT number
- NCT02195869
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-14
- Primary completion
- 2017-09-15
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.